Jyong Biotech Ltd. Ordinary Shares Market Cap ($138.82 Million)
Market Cap & Net Worth: Jyong Biotech Ltd. Ordinary Shares (MENS)
Jyong Biotech Ltd. Ordinary Shares market cap. Jyong Biotech Ltd. Ordinary Shares (NASDAQ:MENS) has a market capitalization of $138.82 Million ($138.82 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17765 globally and #4198 in its home market, demonstrating a 5.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jyong Biotech Ltd. Ordinary Shares's stock price $1.87 by its total outstanding shares 74233667 (74.23 Million). Also see MENS cash flow metrics for how efficiently the company converts equity into cash flow.
Jyong Biotech Ltd. Ordinary Shares Market Cap History (2025–2026)
Jyong Biotech Ltd. Ordinary Shares market cap history from 2025 to 2026. Data shows growth from $293.22 Million to $138.82 Million (0.00% CAGR). Check MENS stock price for real-time trading data and today's change.
Jyong Biotech Ltd. Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jyong Biotech Ltd. Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jyong Biotech Ltd. Ordinary Shares equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MENS by Market Capitalization
Companies near Jyong Biotech Ltd. Ordinary Shares in the global market cap rankings as of November 4, 2026. Also see Jyong Biotech Ltd. Ordinary Shares assets under control for a full breakdown of the balance sheet.
Key companies related to Jyong Biotech Ltd. Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Jyong Biotech Ltd. Ordinary Shares (2025–2026)
Market capitalization of Jyong Biotech Ltd. Ordinary Shares from 2025 to today. Between 2025 and today, Jyong Biotech Ltd. Ordinary Shares's market cap moved from $293.22 Million to $ 138.82 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $138.82 Million | -52.66% |
| 2025 | $293.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Jyong Biotech Ltd. Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $138.82 Million USD |
| MoneyControl | $138.82 Million USD |
| MarketWatch | $138.82 Million USD |
| marketcap.company | $138.82 Million USD |
| Reuters | $138.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for t… Read more